Content about Treatment of bipolar disorder

April 25, 2012

Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

MUMBAI, India — Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

Sun announced the launch of olanzapine tablets in the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths.

The drug is a generic version of Eli Lilly's Zyprexa, used to treat schizophrenia and bipolar disorder. The branded drug and generic versions had sales of $3.28 billion during the 12-month period ended in January, according to IMS Health.

 

April 24, 2012

Dr. Reddy's Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.

HYDERABAD, India — Dr. Reddy's Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.

Dr. Reddy's announced the launch of olanzapine tablets in the 2.5-mg, 5-mg, 7.5-mg, 10-mg and 15-mg strengths.

The drug is a generic version of Zyprexa, used to treat schizophrenia and bipolar disorder. Generic and branded versions of the drug had sales of about $3.28 billion during the 12-month period ended in January, according to IMS Health.

April 24, 2012

Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.

PITTSBURGH — Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.

Mylan announced the launch of olanzapine tablets in the 2.5-mg, 5-mg, 7.5-mg, 10-mg, 15-mg and 20-mg strengths.

The drug, a generic version of Eli Lilly's Zyprexa, is used to treat schizophrenia and bipolar disorder. Various versions of the drug had sales of about $3.3 billion in 2011, according to IMS Health.

March 28, 2012

Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.

NEW YORK — Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.

Dr. Reddy's Labs, Teva and Mylan announced Wednesday the launch of their respective versions of quetiapine fumarate tablets, generic formulations of AstraZeneca's Seroquel, in strengths ranging from 25 mg to 400 mg.

March 5, 2012

Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.

HYDERABAD, India — Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.

The company announced the launch of ziprasidone hydrochloride capsules in the 20-mg, 40-mg, 60-mg and 80-mg strengths.

The drug is a generic version of Pfizer's Geodon, which had sales of $1.34 billion in 2011, according to IMS Health.

February 3, 2012

Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

NORTH WALES, Pa. — Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

Teva announced the launch of olanzapine orally disintegrating tablets in the 5-mg, 10-mg, 15-mg and 20-mg strengths in blister packs of 30.

The drug is a generic version of Eli Lilly's Zyprexa Zydis, used to treat schizophrenia and bipolar disorder.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

December 14, 2011

A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.

MOUNTAIN VIEW, Calif. — A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.

November 10, 2011

A recent study gauging the impact of consuming more fish oil showed a marked reduction both in inflammation and in anxiety among a cohort of healthy young people, the Ohio State University Center for Clinical and Translational Science announced Wednesday.

COLUMBUS, Ohio — A recent study gauging the impact of consuming more fish oil showed a marked reduction both in inflammation and in anxiety among a cohort of healthy young people, the Ohio State University Center for Clinical and Translational Science announced Wednesday.

October 27, 2011

A company focused on developing niche generic and specialty pharmaceutical products has received regulatory approval from the Food and Drug Administration for its version of a psychiatric drug.

PISCATAWAY, N.J. — A company focused on developing niche generic and specialty pharmaceutical products has received regulatory approval from the Food and Drug Administration for its version of a psychiatric drug.

Innopharma said its abbreviated new drug application for olanzapine injection, a generic equivalent of Zyprexa injection. With this approval, Innopharma announced that it has entered an agreement with Sandoz, who will sell, market and distribute Innopharma's generic in the United States.

October 24, 2011

The Food and Drug Administration has approved the first generic versions of two drugs made by Eli Lilly for treating schizophrenia and bipolar disorder, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved the first generic versions of two drugs made by Eli Lilly for treating schizophrenia and bipolar disorder, the agency said Monday.

The FDA announced the approval of generic olanzapine tablets and olanzapine orally disintegrating tablets, respectively generic versions of Lilly's Zyprexa and Zyprexa Zydus. Dr. Reddy's Labs and Teva Pharmaceuticals USA will manufacture olanzapine tablets, while Dr. Reddy's, Apotex and Par Pharmaceuticals will manufacture the orally disintegrating version.

October 20, 2011

Prasco Labs will make authorized generic versions of two psychiatric drugs made by Eli Lilly under a partnership between the two companies announced Thursday.

CINCINNATI — Prasco Labs will make authorized generic versions of two psychiatric drugs made by Eli Lilly under a partnership between the two companies announced Thursday.

Prasco will market authorized generic versions of Zyprexa (olanzapine) tablets and Zyprexa Zydis orally disintegrating tablets. The drugs are used to treat schizophrenia and bipolar disorder. Financial terms of the deal were not disclosed.

October 19, 2011

There’s a new fish oil on the market, and one that doesn’t have a chance at producing a fish “burp” — krill oil.

MISSION HILLS, Calif. — There’s a new fish oil on the market, and one that doesn’t have a chance at producing a fish “burp” — krill oil. Sales of essential fatty acids like those found in krill oil were up 5.5% for the 12 weeks ended Sept. 4 to $76.7 million, according to SymphonyIRI Group data across food, drug and mass (excluding Walmart).


October 7, 2011

Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.

NEW YORK — Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.

The company settled with Handa Pharmaceuticals and also with Accord Healthcare and Intas Pharmaceuticals over two generic versions of the bipolar disorder and schizophrenia treatment Seroquel XR (quetiapine fumarate) extended-release tablets.

October 7, 2011

A popular breast cancer treatment may pose an increased risk of diabetes among older women, according to a new study.

NEW YORK — A popular breast cancer treatment may pose an increased risk of diabetes among older women, according to a new study.

The research, which was published in the latest issue of Cancer, found that among more than 14,000 breast cancer survivors, ages 65 years and up, 10% were diagnosed with diabetes over a 5-year period. However, the likelihood of developing diabetes was 25% more among those taking breast cancer drug tamoxifen.

September 28, 2011

A new report from the Department of Health and Human Services' Agency for Healthcare Research and Quality found little evidence to support the use of atypical antipsychotic drugs for uses other than those for which they have official approval.

ROCKVILLE, Md. — A new report from the Department of Health and Human Services' Agency for Healthcare Research and Quality found little evidence to support the use of atypical antipsychotic drugs for uses other than those for which they have official approval.

August 10, 2011

Omega-3 polyunsaturated fats, or PUFAs, found in seafood may reduce arterial stiffness and improve heart function in chronic heart failure, according to new research released Wednesday.

DENVER — Omega-3 polyunsaturated fats, or PUFAs, found in seafood may reduce arterial stiffness and improve heart function in chronic heart failure, according to new research released Wednesday.

"The consumption of nearly 1 g of omega-3s per day may improve the elasticity of the arteries, especially in individuals at high risk of heart disease," PUFA Newsletter editor Joyce Nettleton said. "Measurement of arterial stiffness is a powerful predictor of future heart events and the risk of dementia and death."

July 11, 2011

Generic drug maker Amneal has launched three new liquid drugs, the company said Monday.

BRIDGEWATER, N.J. — Generic drug maker Amneal has launched three new liquid drugs, the company said Monday.

July 7, 2011

Positioned as the first all-natural line made with certified organic hemp seed oil is the North American Hemp line of personal products. The collection includes bath, body and hair care products all made with certified organic hemp seed oil. According to the manufacturer, hemp has excellent healing and moisturizing properties, and hemp seed oil in hair care products provides rich omega-3, -6, and -9 essential fatty acids.

Positioned as the first all-natural line made with certified organic hemp seed oil is the North American Hemp line of personal products. The collection includes bath, body and hair care products all made with certified organic hemp seed oil. According to the manufacturer, hemp has excellent healing and moisturizing properties, and hemp seed oil in hair care products provides rich omega-3, -6, and -9 essential fatty acids. Hemp seed oil also benefits skin.

June 20, 2011

Johnson & Johnson is recalling 40,000 bottles of a drug used to treat schizophrenia due to consumer reports of the drug having a strange odor, the company said Friday.

TITUSVILLE, N.J. — Johnson & Johnson is recalling 40,000 bottles of a drug used to treat schizophrenia due to consumer reports of the drug having a strange odor, the company said Friday.

J&J subsidiary Ortho-McNeil-Janssen Pharmaceuticals announced the voluntary recall of one lot of Risperdal (risperidone) tablets in the 3-mg strength and a lot of authorized generic risperidone tablets in the 2-mg strength made by Patriot Pharmaceuticals, also a J&J subsidiary.

May 23, 2011

The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.

PITTSBURGH — The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.

Mylan said Monday that the FDA had approved its divalproex sodium capsules in the 125-mg strength. The drug is a generic version of Abbott’s Depakote Sprinkle capsules and is used to treat certain types of epileptic seizures.

Divalproex sodium capsules had sales of about $89 million during the 12-month period ended in March, according to IMS Health.

May 23, 2011

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


SUPPLIER NEWS — The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


May 20, 2011

The Council for Responsible Nutrition on Thursday issued a statement regarding the growing controversy surrounding Lazy Cakes — a brownie containing melatonin, an ingredient that helps establish more normal sleeping patterns — that has been cited in a New York Times article as having “flagrantly mimic[ked] the soothing effects of hash brownies.”

WASHINGTON — The Council for Responsible Nutrition on Thursday issued a statement regarding the growing controversy surrounding Lazy Cakes — a brownie containing melatonin, an ingredient that helps establish more normal sleeping patterns — that has been cited in a New York Times article as having “flagrantly mimic[ked] the soothing effects of hash brownies.”

Other published reports suggested the Arizona Department of Health issued a mandatory recall of Lazy Cakes following the report of an adverse event.

April 11, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

TITUSVILLE, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

J&J said Monday that the FDA had approved Invega (paliperidone) extended-release tablets for patients ages 12 to 17 years. The drug is marketed by J&J subsidiary Ortho-McNeil-Janssen Pharmaceuticals. The drug originally was approved in 2006 for treating schizophrenia in adults.

April 4, 2011

Canadian drug maker Intellipharmaceutics International is seeking approval for a generic version of a treatment for mental disorders.

TORONTO — Canadian drug maker Intellipharmaceutics International is seeking approval for a generic version of a treatment for mental disorders.

Intellipharmaceutics announced Monday that it had filed an application with the Food and Drug Administration for quetiapine fumarate extended-release tablets, a generic version of AstraZeneca’s Seroquel XR.

March 4, 2011

Pregnant mothers taking a common drug for treating epilepsy may be putting their babies at risk, according to a new report from the Food and Drug Administration.

SILVER SPRING, Md. — Pregnant mothers taking a common drug for treating epilepsy may be putting their babies at risk, according to a new report from the Food and Drug Administration.

The FDA said Friday that the drug topiramate could increase the risk for such birth defects as cleft palate and cleft lip when used by expectant mothers. Johnson & Johnson markets the drug under the name Topamax, and it is available in generic form.